Payer+Provider's Health System Review
Gastro Health names interim CEO
FDA approves interchangeable biosimilar to Soliris
May 29, 2024
Optum has spent $31 billion on acquisitions in the last two years, The Oregonian reported May 13.
Read the full post on Becker's ASC